“Identification of Malignancy Risk Factors in Endometrial Pathologies: The Role of Clinical, Laboratory Parameters, and Peripheral Blood Inflammatory Indices”

Integrating clinical and laboratory parameters with PBII, particularly PIV, may be a valuable, noninvasive tool for the early detection and risk stratification of endometrial malignancies. This approach could enhance diagnostic accuracy, reduce the need for invasive biopsies, and improve patient management.